BNP Paribas Financial Markets’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $216K | Buy |
21,212
+18,315
| +632% | +$197K | ﹤0.01% | 4017 |
|
|
2025
Q4 | $30.9K | Buy |
2,897
+559
| +24% | +$6.69K | ﹤0.01% | 4897 |
|
|
2025
Q3 | $32K | Buy |
2,338
+1,187
| +103% | +$16.6K | ﹤0.01% | 4780 |
|
|
2025
Q2 | $16.2K | Sell |
1,151
-4,002
| -78% | -$52.6K | ﹤0.01% | 4692 |
|
|
2025
Q1 | $69.5K | Sell |
5,153
-5,506
| -52% | -$82.7K | ﹤0.01% | 4174 |
|
|
2024
Q4 | $188K | Buy |
10,659
+187
| +2% | +$3.47K | ﹤0.01% | 3902 |
|
|
2024
Q3 | $200K | Sell |
10,472
-4,289
| -29% | -$82.6K | ﹤0.01% | 3256 |
|
|
2024
Q2 | $322K | Buy |
14,761
+471
| +3% | +$12.6K | ﹤0.01% | 2881 |
|
|
2024
Q1 | $548K | Sell |
14,290
-3,908
| -21% | -$189K | ﹤0.01% | 2790 |
|
|
2023
Q4 | $1.22M | Buy |
18,198
+2,681
| +17% | +$187K | ﹤0.01% | 2274 |
|
|
2023
Q3 | $1.16M | Buy |
15,517
+5,856
| +61% | +$520K | ﹤0.01% | 2230 |
|
|
2023
Q2 | $890K | Sell |
9,661
-680
| -7% | -$60.5K | ﹤0.01% | 2280 |
|
|
2023
Q1 | $1.07M | Buy |
10,341
+2,629
| +34% | +$291K | ﹤0.01% | 2268 |
|
|
2022
Q4 | $890K | Sell |
7,712
-4,844
| -39% | -$564K | ﹤0.01% | 2226 |
|
|
2022
Q3 | $1.36M | Buy |
12,556
+4,137
| +49% | +$593K | ﹤0.01% | 2243 |
|
|
2022
Q2 | $1.52M | Buy |
8,419
+2,329
| +38% | +$417K | ﹤0.01% | 1930 |
|
|
2022
Q1 | $1.04M | Sell |
6,090
-5,820
| -49% | -$1.1M | ﹤0.01% | 2288 |
|
|
2021
Q4 | $2.49M | Sell |
11,910
-10,772
| -47% | -$2.23M | ﹤0.01% | 1836 |
|
|
2021
Q3 | $4.37M | Buy |
22,682
+9,417
| +71% | +$2.32M | 0.01% | 1384 |
|
|
2021
Q2 | $3.75M | Buy |
13,265
+6,683
| +102% | +$1.81M | 0.01% | 1447 |
|
|
2021
Q1 | $1.39M | Buy |
6,582
+1,187
| +22% | +$284K | ﹤0.01% | 1929 |
|
|
2020
Q4 | $1.06M | Buy |
5,395
+1,923
| +55% | +$340K | ﹤0.01% | 1988 |
|
|
2020
Q3 | $571K | Buy |
3,472
+2,673
| +335% | +$440K | ﹤0.01% | 2139 |
|
|
2020
Q2 | $111K | Sell |
799
-3,872
| -83% | -$356K | ﹤0.01% | 2728 |
|
|
2020
Q1 | $292K | Sell |
4,671
-38,346
| -89% | -$3.49M | ﹤0.01% | 2655 |
|
|
2019
Q4 | $4.71M | Buy |
43,017
+41,063
| +2,101% | +$3.97M | 0.01% | 1228 |
|
|
2019
Q3 | $202K | Buy |
1,954
+182
| +10% | +$19.6K | ﹤0.01% | 2744 |
|
|
2019
Q2 | $227K | Sell |
1,772
-1,186
| -40% | -$165K | ﹤0.01% | 2535 |
|
|
2019
Q1 | $377K | Buy |
2,958
+1,175
| +66% | +$149K | ﹤0.01% | 2284 |
|
|
2018
Q4 | $223K | Buy |
1,783
+453
| +34% | +$77.5K | ﹤0.01% | 2055 |
|
|
2018
Q3 | $295K | Sell |
1,330
-20,126
| -94% | -$4.08M | ﹤0.01% | 2239 |
|
|
2018
Q2 | $3.44M | Buy |
21,456
+17,958
| +513% | +$2.3M | 0.01% | 1283 |
|
|
2018
Q1 | $327K | Sell |
3,498
-28,882
| -89% | -$2.16M | ﹤0.01% | 2485 |
|
|
2017
Q4 | $2.26M | Buy |
32,380
+26,674
| +467% | +$1.77M | ﹤0.01% | 1421 |
|
|
2017
Q3 | $339K | Buy |
5,706
+1,517
| +36% | +$75.5K | ﹤0.01% | 2181 |
|
|
2017
Q2 | $174K | Buy |
4,189
+1,939
| +86% | +$84.3K | ﹤0.01% | 2537 |
|
|
2017
Q1 | $99.8K | Sell |
2,250
-172
| -7% | -$7.4K | ﹤0.01% | 2497 |
|
|
2016
Q4 | $101K | Buy |
2,422
+792
| +49% | +$31.9K | ﹤0.01% | 2520 |
|
|
2016
Q3 | $61.6K | Sell |
1,630
-1,457
| -47% | -$52.2K | ﹤0.01% | 2339 |
|
|
2016
Q2 | $103K | Buy |
3,087
+1,534
| +99% | +$49.5K | ﹤0.01% | 2107 |
|
|
2016
Q1 | $46.9K | Sell |
1,553
-443
| -22% | -$12.9K | ﹤0.01% | 2017 |
|
|
2015
Q4 | $60.6K | Sell |
1,996
-251
| -11% | -$7.47K | ﹤0.01% | 2674 |
|
|
2015
Q3 | $60.4K | Buy |
2,247
+1,343
| +149% | +$39.1K | ﹤0.01% | 2723 |
|
|
2015
Q2 | $29.2K | Buy |
904
+617
| +215% | +$19.6K | ﹤0.01% | 2818 |
|
|
2015
Q1 | $8.6K | Buy |
+287
| New | +$9.11K | ﹤0.01% | 2838 |
|
|
2014
Q4 | – | Sell |
-862
| Closed | -$28.3K | – | 2693 |
|
|
2014
Q3 | $28.3K | Buy |
862
+771
| +847% | +$23.7K | ﹤0.01% | 2933 |
|
|
2014
Q2 | $2.77K | Buy |
+91
| New | +$2.84K | ﹤0.01% | 2917 |
|
|
2014
Q1 | – | Sell |
-178
| Closed | -$4.65K | – | 3638 |
|
|
2013
Q4 | $4.65K | Buy |
+178
| New | +$4.56K | ﹤0.01% | 3138 |
|
Other funds holding MED
SCP
VCM
BNP Paribas Financial Markets's MED Position: Q1 2026 in Review
BNP Paribas Financial Markets increased its Medifast (MED) stake by 632% in Q1 2026, buying an estimated $197K and bringing the position to 21,212 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #4017.
BNP Paribas Financial Markets first reported a position in MED in Q4 2013 and has held it in 48 quarters since. The position peaked at $4.71M in Q4 2019. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- BNP Paribas Financial Markets held 21,212 shares of Medifast worth $216K as of Q1 2026.
- BNP Paribas Financial Markets bought 18,315 Medifast shares in Q1 2026, an estimated $197K.
- Medifast made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4017 holding.
- BNP Paribas Financial Markets first reported a position in Medifast in Q4 2013 and has held it in 48 quarters since.
- BNP Paribas Financial Markets's Medifast position peaked at $4.71M in Q4 2019.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.